Dominik Lysek, PhD, MChem is a trained chemist, with a PhD in structural biology as well as a successful entrepreneur. After leading the clinical research group in a biomaterial company, he founded credentis in January 2010, in order to established the first biomimetic technology to treat dental caries and enable the Guided Enamel Remineralisation Therapy. Throughout the decade Dr. Lysek was the CEO, raised multiple financing rounds, developed a whole portfolio of products and finally had a successful exit in November 2020. Today, he works as an angel investor and is on the board of healthcare companies as well as philanthropic foundations. Dr. Lysek is passionate about bringing cutting-edge scientific innovations into the oral care field, and turning them into commercial successes.